- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens installs first AS 20-slice CT
Viztek crafts mini-PACSHologic contraceptive gains FDA approval
Siemens installs first AS 20-slice CT
The Center for Diagnostic Imaging in Milwaukee, WI, is the first to receive Siemens new 20-slice Somatom Definition AS 20 CT scanner. Key advantages of the scanner, according to the company, are reduced radiation dose a 31-inch (78 cm) gantry bore, and optional 660 pounds (300 kg) weight capacity of the patient table. The Definition AS 20, which can be field upgraded to 40-slice, 64-slice, and 128-slice configurations, supports perfusion imaging of the brain and other organs.
Viztek crafts mini-PACS
Viztek has added a customizable mini PACS to its Opal line of healthcare IT systems. Designed for smaller practices, the scalable Opal-WS allows facilities to choose features, storage space, and Web components based on size and image volume. Users can login from any Web-enabled PC.
Hologic contraceptive gains FDA approval
Its 2007 merger with Cytyc dramatically extended the product offerings of Hologic. This week the company, best known for mammography and bone densitometry, announced FDA approval of a minimally-invasive alternative to surgical permanent contraception. In January 2009, Hologic received CE marking approval for the system, dubbed Adiana, and started marketing and sales of the product in certain European countries. The procedure using this product requires no incisions and can be performed in a doctor's office under local anesthesia.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
